ArticleMaterials today. Bio2026
Enhanced hemostasis and bone regeneration achieved by thrombin-simvastatin-polydopamine loaded spray-dried β-TCP/ gelatin/ soy protein isolate biocomposites in critical rat calvarial defects.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Effective bone tissue engineering strategies require scaffolds with tailored properties to address specific bone abnormalities and fractures. Herein, porous biocomposite scaffolds were fabricated via repeated freeze-casting and three-layer coating. The prepared system consisted of spray-dried β-TCP granules and bio-macromolecule gelatin-based soya protein isolate (S) combined with a layer of the biomimetic adherent poly-dopamine (PDA) for simvastatin (SIM) coating via dopamine self-polymerization through the dip-coating process. Thrombin (Th) was then loaded to make the final hemostatic hybrid bone graft (TGS/SIM/Th). The PDA adhered layer improved the mechanical qualities as expected (13.93 MPa). Additionally, MC3T3-E1 cell migration (>90%) and osteogenic differentiation (∗∗∗p < 0.001) were superior in vitro. The sustained release of SIM (∼78%) can help form new capillary networks, and the burst release of Th (∼97.2%) supports the creation of stable blood coagulation. The hemostatic time of the TGS/SIM/Th significantly decreased (∗∗∗∗p < 0.0001) in the critical-sized rat calvarial defect model and tail amputation model, which would effectively enhance the bone repair. This study shows that the fabricated biocomposite could represent a new approach for treating bone defects while absorbing a large amount of blood from onsite bleeding.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.